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Summary
Schizophrenia is a severe mental disorder affecting ∼1%
of the world’s population. Here, we report the results
from a three-stage genomewide screen performed in a
study sample from an internal isolate of Finland. An
effort was made to identify genes predisposing for
schizophrenia that are potentially enriched in this isolate,
which has an exceptionally high lifetime risk for this
trait. Ancestors of the local families with schizophrenia
were traced back to the foundation of the population in
the 17th century. This genealogical information was
used as the basis for the study strategy, which involved
screening for alleles shared among affected individuals
originating from common ancestors. We found four
chromosomal regions with markers revealing pairwise
LOD scores 11.0: 1q32.2-q41 ( , dominantZ = 3.82max
affecteds-only model), 4q31 ( , dominantZ = 2.74max
90%-penetrance model), 9q21 ( , dominantZ = 1.95max
90%-penetrance model), and Xp11.4-p11.3 (Z =max
, recessive 90%-penetrance model). This finding2.01
suggests that there are several putative loci predisposing
to schizophrenia, even in this isolate.
Introduction
Schizophrenia (MIM 181500) is a mental disorder char-
acterized by delusions, hallucinations, disturbed think-
ing, and bizarre behavior. The prevalence of schizo-
phrenia varies; the disorder occurs in ∼1% of most
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populations that have been studied, although some local
subpopulations with a notably higher prevalence have
been described (Bo¨o¨k et al. 1978; Hovatta et al. 1997).
On the basis of the results of twin and adoption studies,
genetic components, in combination with environmental
factors, seem to play a role in the etiology of the disease
(Tienari et al. 1987; Cannon et al. 1998).
To date, the results of several genomewide scans have
been published; these findings are from family studies
done in a number of different, mostly heterogeneous
white populations (Barr et al. 1994; Coon et al. 1994;
Moises et al. 1995; Levinson et al. 1998). The results
of these studies and other, not fully published genome
screens have shown some evidence of linkage to several
chromosomal regions, including 2q (Levinson et al.
1998), 3p (Pulver et al. 1995), 4q (Levinson et al. 1998),
5q (Straub et al. 1997), 6p (Moises et al. 1995; Wang
et al. 1995), 8p (Pulver et al. 1995), 9 (Moises et al.
1995; Levinson et al. 1998), 10q (Levinson et al. 1998),
11q (Levinson et al. 1998), 20 (Moises et al. 1995), and
22q (Coon et al. 1994; Pulver et al. 1994), that might
harbor genes predisposing to schizophrenia. To date, the
statistical significance of the findings and the subsequent
replication attempts has not been conclusive, and, de-
spite the intensive work being done, positional cloning
efforts have not yet revealed any specific susceptibility
genes for schizophrenia.
To increase the power to detect correlations between
genetic markers and the disease gene, studies of isolated
human populations have been undertaken. In small ho-
mogeneous populations, the genetic variability can be
substantially reduced, and the environmental and cul-
tural variabilities are, likewise, typically much lower
than those in larger, more-cosmopolitan populations.
Furthermore, in populations with a very small number
of founders, the correlation between marker loci and the
disease gene may also be increased as a result of the
greater potential for linkage disequilibrium (LD) to be
created and maintained (Thompson and Neel 1978;
O’Brien et al. 1994; Terwilliger et al. 1998). All these
factors should increase the chances of detecting at least
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some possible genetic loci, while decreasing the noise
caused by other etiologic agents.
Elsewhere, we have described an isolate with 18,000
inhabitants in the northeastern part of Finland, where
the age-corrected lifetime risk of schizophrenia is 3.2%,
compared with the national average risk of 1.1% (Hov-
atta et al. 1997). This subpopulation was founded, by
40 families, at the end of the 17th century, and precise
details of the subpopulation’s births, deaths, marriages,
and movements, kept by the Finnish Church, have been
preserved. A well-known population history and high-
quality health-care records, including hospitalizations
and medications, make this isolate valuable for molec-
ular genetic studies. Here, we describe the data obtained
from a genome scan performed in this unique study sam-
ple with well-established genealogy.
Material and Methods
Genealogical Search
The genealogical study was performed in accordance
with published criteria (Varilo et al. 1996). The names,
dates, and places of birth of each patient’s parents were
used to trace ancestors from local church registries. Mi-
crofilm copies of records obtained from the Finnish Na-
tional Archives were used for earlier periods.
Collection of the Families
All patients with schizophrenia who were born be-
tween 1940 and 1969 and who have either been hos-
pitalized for schizophrenia or receive, from the Social
Insurance Institution of Finland, a free-medication or
disability pension for schizophrenia were identified in
Finland ( ). These data were linked with datan = 29,124
from the National Population Register to find first-de-
gree relatives of the patients and to construct families
with multiple affected individuals (Hovatta et al. 1997).
We could identify a total of 365 families with at least
one patient with schizophrenia and with at least one of
the parents born in the isolate. The number of families
with at least two affected siblings was 69 (Hovatta et
al. 1997). A 20-ml EDTA blood sample was collected
from all available family members who were willing to
participate in the study and who came from families with
at least two affected children ( ). In addition, bloodn = 20
samples from single affected patients with parents were
collected ( ). This study has been approved by then = 25
ethical review board of the National Public Health In-
stitute of Finland.
All available inpatient and outpatient case notes
were collected for probands and relatives with any
psychiatric diagnosis in any of the registers or for any
psychiatric disturbance reported by key informants.
Two pairs of psychiatrists, who were blind to the fam-
ily structure, independently made a lifetime diagnosis
of schizophrenia, according to the Diagnostic and Sta-
tistical Manual of Mental Disorders, 4th Edition
(DSM-IV). One of them also filled out the Operational
Criteria (OPCRIT) checklist (McGuffin et al. 1991).
In instances of diagnostic disagreement, a third psy-
chiatrist reanalyzed the case to achieve consensus
best-estimate DSM-IV lifetime diagnoses. The relia-
bility of the diagnoses was tested using the k statistic.
Both J.S. and R.A. rated the diagnoses of 66 patients.
The k values (95% confidence interval) were excellent
for schizophrenia, .907 (.805–1.010); schizoaffective
psychosis, .816 (.612–1.019); liability class 3 (schizo-
phrenia spectrum diagnoses), .817 (.568–1.067); and
liability class 4 (bipolar disorder and major depressive
disorder), .891 (.742–1.040). Both J.S. and M.-L.K.-
S. rated the diagnoses of 25 patients without any dis-
agreements. J.S. and H.J. agreed on the diagnoses of
three patients, whereas one other patient was rated,
by H.J., as having schizophrenia and, by J.S., as hav-
ing schizoaffective disorder. We chose not to conduct
direct interviews in this stage of the study, because
the reliability of the diagnosis of schizophrenia in the
Hospital Discharge Register of Finland has been as-
sessed in several studies, and it has been shown to be
good (Pakaslahti 1987; Isohanni et al. 1997; Cannon
et al. 1998; Ma¨kikyro¨ et al. 1998). Therefore, we were
able to identify every inpatient treatment for each pa-
tient and to contact the treating hospital. The out-
patient clinic for treatment was identified through the
treating psychiatrist.
DNA Analysis
DNA samples were extracted, from 20-ml EDTA
blood, according to a standard procedure (Blin and Staf-
ford 1976) modified to adapt Phase Lock Gel tubes (5′r
3′). PCR amplification and gel electrophoresis performed
with the use of either the A.L.F.express automated DNA
sequencer or radioactivity have been described elsewhere
(Pekkarinen et al. 1998).
Genome Scan Stage I
We typed 351 microsatellite markers from a modified
Weber screening set, version 6.0, in 17 affected individ-
uals from the large pedigree shown in figure 1 and in
18 controls (Sheffield et al. 1995). The average inter-
marker distance was 10.9 cM, with the largest gap being
28 cM on the X chromosome. Some of the markers were
replaced with markers from the Ge´ne´thon marker map
(Dib et al. 1996). All affected individuals had a DSM-
IV diagnosis of schizophrenia. Controls were either
healthy married individuals from the large pedigree
( ) or healthy individuals from other families withn = 8
schizophrenia that were collected from the isolate (n =
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Figure 1 Large pedigree from the isolate with a founder couple born in approximately 1650. Circles represent females; squares represent
males. Blackened circles and squares represent individuals with at least two children affected with schizophrenia.
). Two case-control association tests were used to an-10
alyze the data from these 17 cases and 18 controls. Link-
age analysis was performed, by use of a pseudomarker
approach (Trembath et al. 1997) (see Statistical Analyses
section, below), in nine affected individuals belonging
to two larger reconstructed pedigrees (these individuals
are denoted by an asterisk in fig. 2). Eight of these in-
dividuals were the same individuals who were part of
the association analysis.
Genome Scan Stage II
In stage II, we analyzed 20 families with at least two
affected individuals collected from the isolate (fig. 2). At
this point, all possible connections between these nuclear
families were traced back for three generations, and 13
families were found to be related to 1–4 other families.
Not all of these families could be shown to be linked to
the large pedigree shown in figure 1, even though such
linkage is highly likely. A total of 27 markers meeting
one of the following criteria from the stage I analyses
were genotyped in this additional set of data: (1) markers
yielding a P value ! .01, or pairs of adjacent markers
where both yield in either of the associationP ! .05
tests; (2) markers with a LOD score of in theZ 1 1.01
pseudomarker linkage analysis; and (3) pairs of adjacent
markers that have one allele shared at each marker in
50% of cases (i.e., those markers for which 50% of
cases possibly share a “two-locus haplotype”). These
regions are denoted by red vertical lines in figure 3. The
data were analyzed by use of both model-based linkage
analysis and model-free affected sib-pair analysis. Two
different diagnostic classes were considered: in class 1,
only patients with schizophrenia were considered to be
affected, and, in class 2, patients with schizoaffective
disorder were also considered to be affected. Patients
with schizophrenia-spectrum diagnosis, bipolar disorder,
or major depressive disorder were considered to be of
unknown status throughout.
Genome Scan Stage III
In stage III, a denser marker map was typed on the
four chromosomal regions where markers showed a
LOD score greater than 1.0 in stage II. The markers
analyzed in stage III were chosen from the Ge´ne´thon
marker map and were radioactively labeled. The dis-
tances between the markers were derived from the ge-
netic maps of both The Cooperative Human Linkage
Center and Ge´ne´thon and from the radiation hybrid map
of the Whitehead Institute for Biomedical Research/MIT
Center for Genome Research. The data were evaluated
by linkage and affected sib-pair analyses.
Statistical Analyses
After the first screen, markers were analyzed, under
the assumption of a founder effect, both by a likelihood-
ratio test for LD, and by a contingency-table x22#N
analysis; both analyses were performed by means of the
DISLAMB program (Terwilliger 1995). Pairwise linkage
analysis was performed, by use of the MLINK program
of the LINKAGE package (Lathrop and Lalouel 1984;
Lathrop et al. 1984, 1986), in two subpedigrees con-
taining nine of the typed affected individuals from the
large pedigree (fig. 2). A pseudomarker approach (Trem-
bath et al. 1997; Terwilliger 1998; J. Terwilliger, un-
published data), in which every meiosis was made in-
formative at the trait locus to maximize the power of
this study, was used to perform a traditional linkage
analysis that has properties analogous to an affected
relative-pair design, while also allowing for correlations
to be made between multiple related individuals in an
Figure 2 Families that underwent genotyping in stages II and III. Individuals with a circled number underwent genotyping, and those
with an asterisk underwent linkage analysis in stage I. Individuals with an “H” below the circled number have a putative 6.6-cM haplotype
on chromosome 1. Liability class (LC) 1 includes individuals with a DSM-IV diagnosis of schizophrenia; LC 2, those with schizoaffective
disorder; LC 3, those with schizophreniform disorder, schizotypal personality disorder, schizoid personality disorder, delusional disorder, brief
psychotic disorder, or psychotic disorder not otherwise specified; and LC 4, those with bipolar disorder and major depressive disorder.
1118 Am. J. Hum. Genet. 65:1114–1124, 1999
Figure 3 Results from stage I of the genome screen. The top panel shows results from the pseudomarker LOD-score analysis. The middle
panel shows the results from the x2 test. The bottom panel shows the results from the likelihood ratio test (LRT). For each marker in2#N
the genome scan and for each statistic, the “theoretical P value” for each statistic is plotted on a log scale, such that higher peaks are more
significant than lower peaks. The P values used on the y-axis compare the results of different statistics more easily, since they are expressed in
a common currency. Red vertical lines indicate regions that were followed up in stage II.
efficient and unbiased manner, as described elsewhere
(Trembath et al. 1997). This algorithm has been shown
elsewhere to consistently be among the most powerful
model-free methods, under a variety of true states of
nature (Davis and Weeks 1997). LOD scores derived
from this analysis are presented as Z1.
In stages II and III, the genotype data were analyzed
by pairwise linkage analysis, with the use of dominant
and recessive inheritance models and two different pen-
etrances, a 90%-penetrance model and an analogous
affecteds-only model. No phenocopies were allowed,
and a disease-gene frequency of .001 was assumed. Re-
sults from this linkage analysis are presented as Z2. Pair-
wise linkage analysis was performed with the use of the
LINKAGE package (Lathrop and Lalouel 1984; Lathrop
et al. 1984, 1986), and the heterogeneity analysis was
performed with the use of the HOMOG program (Ott
1986). Sib-pair analysis was performed by means of the
SIBPAIR program (Kuokkanen et al. 1996).
Simulation of the Population Subisolate
To examine the effects of the inbred population struc-
ture on the power of association studies in this data, a
population simulation study was done with the use of
the algorithm described elsewhere (Terwilliger et al.
1998) (data available from the authors of the present
study). The power to detect some evidence of LD in this
study is good, although, as in the case of a complex
disease, it is not expected to find a single disease-asso-
ciated haplotype shared by all affected individuals—in
contrast to the rare diseases of the Finnish disease her-
itage (Ho¨glund et al. 1995; Nikali et al. 1995; Varilo et
al. 1996).
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Estimation of the Genomewide Significance
Since this population began, with a maximum of 160
chromosomes, in the 17th century and since today there
are 136,000 chromosomes, there should be a high
amount of identity by descent from these founders. Com-
bined with the unavoidability of there being consan-
guinities over several generations in a finite closed sys-
tem, the conventional assumptions of Hardy-Weinberg
equilibrium and linkage equilibrium are not expected to
hold true. For this reason, several statistical analyses
were performed to address the genomewide significance
of our findings. First, the inbreeding coefficients Fis and
Fst were estimated. Fst is normally used to measure dif-
ferentiation between allele-frequency distributions in
two populations. We defined the cases and controls as
“populations” and measured the degree of difference
between these two populations genetically. Our hypoth-
esis was that, near a disease gene, the differentiation
would be larger, and, in other regions, it would fluctuate
around some fixed value (which would be 0 if the cases
and controls were randomly sampled from the whole
population, but which would be some value 10 in this
example, since the cases are more closely related to each
other than they are to the controls). Although Fst is math-
ematically related to the contingency-table sta-2#N
tistic we presented in figure 3 (Weir 1996), it has the
property of being a quantifiable measurement of the
strength of the association, which is not as dependent
on the marker-allele frequencies as are the P values in
that graph.
Second, we used a permutation test to determine
whether our cases are more closely related to each other
than they are to the controls. According to the null hy-
pothesis of independence of the case and control sam-
ples, the marker-locus genotypes should be independent
of the phenotype. Since it is possible that marker-locus
genotypes may be correlated within individuals (i.e., LD
may exist), the phenotypes were randomized for each
individual, keeping the genotypes fixed across the entire
genome-spanning set of markers. In each replicate, a set
of 17 of the 35 genotyped individuals were randomly
assigned to be “cases,” and the remaining 18 individuals
were designated as “controls”; association analyses were
repeated for every marker in the genome. For each rep-
licate, the number of observed P values !.05, .01, and
.001 was determined, and this process was repeated
1,000 times to determine the expected genomewide rate
of false positives for each statistic.
Simulations on the Significance of the Chromosome 1
Haplotype
To test the significance of the shared 6.6-cM haplotype
in chromosome 1, which was found in the linkage anal-
ysis of extended pedigree B (fig. 2), we used the following
method. We generated random chromosomes for the
founders in pedigree B, by use of the marker maps from
genome scan stage III. For allele frequencies, we used
the frequencies from the whole study population. For
each set of simulated chromosomes, we then simulated
the meioses in the pedigree, with recombination prob-
ability depending on the genetic distance. For the re-
sulting chromosomes of the 10 affected individuals in
the pedigree, we computed the length of the longest
shared haplotype (identical by state). To test the signif-
icance and frequency of the shared haplotype, further
simulations were performed. Individuals 17 and 18,
25–28, 43–44, and 61–63 were omitted from the anal-
ysis, since they are related to the pedigree only through
marriage. At least eight individuals were required to have
the haplotype.
This simulation estimate is potentially vulnerable to
undetected relationships between the founders of the
pedigree. To test the possible effect of such relationships,
we evaluated the findings when: (1) the two founders of
the pedigree—founders 1 and 2—were assumed to be
second cousins; (2) individuals 17–20 were assumed to
be children of founders 1 and 2; and (3) founders 1 and
2 and individuals 17–20 were all assumed to be second
cousins. These additions to the pedigree did not alter
the results in any significant way.
Results
Genealogical Search
We first performed an extensive genealogical search
to trace the ancestors of identified families with schizo-
phrenia in the isolate. We identified a total of 365 nuclear
families with at least one patient with schizophrenia and
at least one of the parents born in the isolate. Our next
step was to search the nationwide genealogical records
to identify which of these families were related to each
other within the past two generations; 151 families were
found to have such a connection with at least one other
family from the same set of 151 families. This subset of
interrelated nuclear families was then traced back to the
founding families of our northeastern subpopulation in
the 17th century, and it was found to be related along
multiple genealogical paths.
During the second phase of our study, all nuclear fam-
ilies with at least two children affected with schizo-
phrenia were selected. Of the 151 nuclear families, 48
had at least two affected children, and 39 (81%) could
be merged into a single large pedigree, with ∼80 affected
individuals in the last generation and a founder couple
born, approximately, in 1650 (i.e., 7–10 generations
from the patients’ generation; fig. 1). The pedigree pre-
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Table 1
Results from the Permutation Test Showing
Numbers of Markers with Corresponding P
Values
P VALUE
NO. IN GENOME SCREEN
LRT 2#N Both
Observed Positives
!.05 24 24 13
!.01 6 5 3
!.001 1 0 0
!.0001 0 0 0
Expected False Positives
!.05 12.21 15.86 5.929
!.01 2.857 2.429 .750
!.001 .393 .107 .036
!.0001 .036 .000 .000
sented in figure 1 shows only one of the many possible
genealogical connections between the individuals, and,
in reality, the genealogy is much more complex. To iden-
tify all possible connections between individuals would
be an enormous task, and we only wanted to confirm
that patients in the last generation have a common an-
cestor, which would, hopefully, reduce genetic hetero-
geneity among affected individuals.
Genome Scan Stage I and Estimation of the
Genomewide Significance
Results from the first stage of the genome scan are
summarized in figure 3, and numerical details are avail-
able from table A on our web site. The most significant
result obtained from the association tests was seen with
the use of marker D18S542 ( ), and the high-P = .00097
est pairwise LOD score in the linkage analysis (Z =1
) was obtained with marker D2S1399.2.49
Over the entire genomewide association set of data,
the inbreeding coefficient Fis was estimated to be .015,
and, for individual marker loci, the point estimates
ranged between .15 and .22. To quantify the inde-
pendence of case and control samples, a primitive anal-
ysis was performed, with the use of Fst, to measure the
similarity between case and control populations (Ter-
williger 1998). We found significant evidence (P !
) of a mild amount of subdivision ( ), with.001 F = .025st
significance judged by permutation test. This would pro-
vide evidence that the affected individuals in our study
data are more closely related to each other than they are
to the controls. This is not too surprising, since controls
were individuals who married into the pedigree and were
not the members of the large family. Since the basis of
our initial genome scan was the monitoring of shared
alleles among affected individuals, the multiple connec-
tions between family members can be expected to result
in an excessive number of false positive regions. How-
ever, this initial scan was not meant to be conclusive in
itself but, rather, was designed to have maximum sen-
sitivity while, admittedly, leading to the admission of a
few too many false positives.
Similar results were obtained in another permutation
test done on the basis of randomization of the pheno-
types. As shown in table 1, several shared regions among
affected individuals are expected to occur simply by
chance, as a result of inbred pedigree structures. How-
ever, one still expects the cases to be even more similar
to each other with regard to having marker loci located
near a shared disease allele rather than elsewhere in the
genome, and, therefore, the relative significance of the
association tests for different markers, in the context of
the entire genome, should still be useful for discrimi-
nating which regions of the genome are more likely to
harbor a schizophrenia-predisposing locus.
Fst estimates can also be used as a quantifier of the
strength of allelic association between a marker locus
and a disease phenotype (Weir 1996). In this genome
scan, the largest values of Fst were also found for
markers on chromosomes 4 ( ), 10 ( ),F = .13 F = .11st st
and 11 ( ), each of which had a P value !.01.F = .09st
At least in this study, the Fst estimates correlated well
with the P values obtained in the association test.
Genome Scan Stage II
In stage II, we typed, on 19 chromosomal regions in
20 families collected from the isolate, 27 markers that
provided the most interesting results in stage I (see the
Material and Methods section, above, for further de-
tails). Results of the linkage and sib-pair analyses are
shown in table Ba on our web site. We were left with
four markers showing a LOD score of . TheseZ 1 1.02
markers were D1S2141, on chromosome 1, which had
a maximum LOD score of ; D4S1629, on chro-Z = 3.732
mosome 4, which had a maximum LOD score of Z =2
; D9S922, on chromosome 9, which had a maxi-2.36
mum LOD score of ; and DXS6810, on chro-Z = 1.952
mosome X, which had a maximum LOD of score of
.Z = 1.192
Genome Scan Stage III
In stage III, a denser marker map was typed on the
four regions from stage II where markers showed a LOD
score 11.0. On chromosome 1, 11 markers were geno-
typed to an 18-cM region (tables Ca and Cb on our web
site). Three of the markers gave LOD scores ,Z 1 3.02
with the maximum LOD score being , whichZ = 3.822
was attained with marker D1S2891, by use of a dom-
inant affecteds-only model in diagnostic class 2. No sig-
nificant evidence for locus heterogeneity was seen, al-
though the HOMOG program might not optimally
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detect locus heterogeneity, even though it may exist, in
such a small set of family data as ours. In addition, we
observed a 6.6-cM haplotype, consisting of markers
D1S2891, D1S491, D1S205, and D1S425, that is seg-
regating within three of the families with schizophrenia
from this isolate (fig. 2). After initial recognition of the
haplotype, we performed genotyping in 25 additional
patients and their parents from the isolate, but only one
additional patient carried this haplotype, and none of
the 50 nontransmitted chromosomes from the parents
of these individuals had the haplotype (not significant;
). Overall, 12 patients with schizophrenia, 1 pa-P 1 .5
tient with major depressive disorder, 7 healthy siblings
of patients with schizophrenia, and 1 healthy spouse and
his daughter, all of whom were from four families, car-
ried this particular haplotype. One individual in the data
set (pedigree B, individual 63) had two copies of this
haplotype in a homozygous state, yet she was pheno-
typically healthy. A further genealogical search revealed
that her father (individual 58) is a grandson of individual
10’s cousin.
Of the 11 markers typed on chromosome 4, 2 had a
LOD score of , with the maximum LOD scoreZ 1 2.02
being with marker D4S1586, by use of a dom-Z = 2.742
inant model with 90% penetrance and a narrow diag-
nostic class (tables Cc and Cd on our web site). In ad-
dition, an affected sib-pair LOD score of 2.09 (P =
) was observed with this marker. Positive LOD.00097
scores were observed for a fairly large 22-cM region,
but no common haplotype was seen among affected
individuals.
Only one of the six markers typed on chromosome 9,
D9S922, yielded a LOD score of (tables Ce andZ 1 12
Cf on our web site). This is the same marker that was
positive in stages I and II, and the obtained maximum
LOD score was , by use of a dominant modelZ = 1.952
with 90% penetrance under diagnostic class 2.
Several of the nine genotyped chromosome-X markers
showed LOD scores of , with the maximum beingZ 1 12
with marker MAOB, under a recessive inher-Z = 2.012
itance model with 90% penetrance and diagnostic class
1 (tables Cg and Ch on our web site). On this chro-
mosomal region, we also saw positive LOD scores for
a quite-wide region of 15 cM, but no evidence for a
common haplotype emerged among affected individuals.
Simulations on the Significance of the Chromosome 1
Haplotype
We performed simulations to test both the frequency
and the length of the haplotype, to evaluate the effect
of the inbred population structure on the results of the
potential 6.6-cM haplotype shared among affected in-
dividuals. A simulation test (see the Material and Meth-
ods section, above) indicated that the observed amount
of haplotype sharing would occur by chance in our study
sample, with a probability !.001. Further simulation
showed that adding some potentially undetected rela-
tionships between a small number of the founders of the
pedigree did not significantly increase the probability of
the occurrence of such a haplotype. We also tested the
significance of the frequency of the observed haplotype,
by use of a similar simulation method. For each simu-
lated set of chromosomes, we recorded the rarest hap-
lotype that was shared by the eight affected individuals
in the pedigree. The results are shown in table D on our
web site. The frequency of the shared 6.6-cM haplotype
was found to be .0008, on the basis of the allele fre-
quencies of the study population. According to the sim-
ulation, this corresponds to a P value of .0002. These
data would suggest that the putative haplotype does not
represent a by-chance finding in this inbred pedigree.
Discussion
We have performed a three-stage genomewide screen
to identify loci predisposing to schizophrenia in an iso-
lated population of 18,000 inhabitants from northeast-
ern Finland. In this community, the lifetime risk of
schizophrenia is 3.2%, whereas the national average is
1.1% (Hovatta et al. 1997). We made a special effort
to genealogically define our study sample and could con-
firm that affected individuals shared common ancestors;
we based our genome-scan strategy on this information.
We found four chromosomal regions showing LOD
scores 11.0. Estimation of the genomewide significance
level in isolated populations is difficult because of the
high level of inbreeding, and this question has not been
taken into account in many earlier studies dealing with
data sets collected from isolated populations. We made
a special effort to address this problem by performing
several simulation analyses to evaluate the probability
of seeing, in this inbred study sample, sharing of alleles
by chance. In the first stage of the screen, the controls
we selected were healthy individuals who married into
families with schizophrenia, as opposed to family-based
controls. This method requires genotyping only one con-
trol individual, as opposed to two control individuals,
which is necessary when family-based controls are used.
After the first stage of the screen, we observed that the
cases are more closely related to each other than to these
controls. That affected individuals are more closely re-
lated to each other than to the controls provides further
evidence that the controls represent a more random sam-
ple of this isolated subpopulation than do members of
the large pedigree; however, this fact should not increase
the false negative rate of our study but, rather, should
increase the false positive rate. Being aware that some
identified regions are shared by affected individuals sim-
ply as a result of inbreeding, we still pursued further
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analyses of the chromosomal regions showing the most
significant results after the first and second stages.
Linkage analysis in complex diseases is problematic
as a result of inheritance models that are incorporated
into the analysis because the true model is typically un-
known. Some assumptions about the mode of inheri-
tance must be made, and such linkage analysis done with
the use of extended pedigrees has still been, to date, the
most successful gene-mapping protocol of complex dis-
eases (St. George-Hyslop et al. 1987; Hall et al. 1990;
Pericak-Vance et al. 1991; Schellenberg et al. 1992). We
used dominant and recessive inheritance models, initially
with an assumption of 90% penetrance and, subse-
quently, with an analogous affecteds-only model. We
allowed no phenocopies (individuals who are affected
without having the particular susceptibility gene), and
the gene frequency was set to .001. It is obvious that
such models are incorrect, but we wanted to use robust
models to maximize power (Davis and Weeks 1997;
Trembath et al. 1997; Terwilliger 1998). We actually
tested the effect of changing the linkage-analysis param-
eters in a subset of the data. The use of a lower pene-
trance value and a higher disease-gene frequency, in
addition to allowing for phenocopies, did not have
considerable effect on the results; the LOD scores neither
increased nor decreased significantly (data not shown).
In addition to undergoing linkage analysis, the data were
also analyzed with analogous model-free affected sib-
pair methods. Since deviations from Hardy-Weinberg
equilibrium and linkage equilibrium can occur in an in-
bred population, the P values obtained in studies using
isolated populations should be interpreted with caution.
Since we used multiple different models, multiple testing
should be taken into account when interpreting the
results.
The highest pairwise LOD score in this genomewide
scan was , which was obtained with markerZ = 3.822
D1S2891, by use of a dominant affecteds-only model in
linkage analysis and by considering patients with schizo-
phrenia or schizoaffective disorder to be affected. No
significant evidence of locus heterogeneity was found.
On the same chromosomal region, we also observed a
6.6-cM haplotype segregating in four core families. The
haplotype was also seen in healthy family members, and,
assuming a locus for schizophrenia on this region, these
individuals would represent nonpenetrant cases, as is
expected for predisposing loci for a complex disease. The
haplotype was present in 8 of 13 affected individuals in
the largest family, as well as in 8 of 18 healthy individ-
uals. The putative haplotype would narrow, to a much
more restricted 6.6-cM region, the otherwise wide 18-
cM region in which the positive LOD scores are seen.
However, further genotyping with the use of more mark-
ers is needed for additional individuals from the same
community, to confirm the significance of the haplotype
in practice. It will be interesting to know the frequency
of the haplotype both in this community and in the gen-
eral Finnish population. In this study, we used 90% pen-
etrance and low-penetrance affecteds-only models in
linkage analysis. If all haplotype carriers will have the
putative disease gene, the true penetrance of the gene
will be lower, ∼50%. Determining the correct penetrance
of the putative susceptibility gene should increase the
power of linkage analysis.
With the use of the markers analyzed so far, no sta-
tistically significant evidence for LD could be observed,
and it might be possible that extended LD is not de-
tectable in this population for such complex diseases as
schizophrenia (Weiss 1996). However, because of the
young age of the population, the odds are better that,
even with the use of a marker map as sparse as that
used in this study, some evidence of LD will be found
in this population rather than in the larger, more-cos-
mopolitan study populations. The statistical significance
of the observed haplotype, on the basis of simulation
studies, has approximately the same magnitude as the
significance of the linkage finding. Taken together, these
findings add to our confidence that there might be a true
susceptibility locus for schizophrenia in this chromo-
somal region; however, extensive studies in this popu-
lation and in other populations are needed to determine
the frequency of this haplotype in both affected individ-
uals and healthy individuals.
Another promising region was identified on chro-
mosome 4, where the marker D4S1586 resulted in a
maximum LOD score of , by use of a dominantZ = 2.742
model with 90% penetrance and a narrow diagnostic
model. Even though we could not see any evidence for
a shared haplotype among affected individuals, the re-
gion still looks promising, since positive LOD scores are
seen on a fairly large 22-cM region, and the data are
supported by affected sib-pair analysis that reveals a
maximum LOD score of 2.09, with marker D4S1586
corresponding to a P value of .00097.
On chromosome 9, a maximum LOD score of Z =2
was obtained with the marker D9S922, but all sur-1.95
rounding markers showed LOD scores !1.0. Interest-
ingly, positive findings have been reported in genome
screens ∼25 cM from D9S922 (Moises et al. 1995) and
4 cM from the same marker (Levinson et al. 1998).
Clearly, this region needs to be studied by other groups
to determine whether it would harbor a locus predis-
posing to schizophrenia in some families.
In addition, our chromosome-X finding looks inter-
esting because several other groups have also reported
positive results around our best marker, MAOB (an in-
tragenic marker for monoamine oxidase B gene), which
yielded a LOD score of , with a recessive 90%-Z = 2.012
penetrance model and narrow diagnostic classification.
The use of two other markers also resulted in LOD
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scores 11.0. Originally, with the use of marker DXS7,
a maximum LOD score of was reported inZ = 1.832
the close vicinity of MAOB (DeLisi et al. 1994). The
highest LOD score reported on DXS7 is , un-Z = 2.162
der a dominant inheritance model in a multicenter study
(Dann et al. 1997). Some other groups have not been
able to see evidence for linkage on this region (Okoro
et al. 1995), and no sequence variation associated with
schizophrenia could be seen when the MAOB gene was
screened, by dideoxy fingerprinting, in 100 male patients
(Sobell et al. 1997). In an association study (Coron et
al. 1996), no significant difference in allele frequencies
was observed between patients and controls, but a trend
toward an association between allele 1 of the MAOB
gene and paranoid schizophrenia was found.
In sum, in this study, in which we aimed to maxi-
mize the benefits of genetically isolated populations
in the search of complex disease loci, positive results
for the schizophrenia trait were obtained on four
chromosomal regions: 1q32.2-q41, 4q31, 9q21, and
Xp11.4-p11.3. That they were found warrants further
studies in this family set and in independent family
sets from other populations, to determine the signif-
icance of these findings in other parts of Finland and
in other ethnic groups. Although we are cautious
about the significance of these loci until further ex-
amination has been done, our results from this ge-
nome screen may eventually help to identify specific
genes contributing to susceptibility to schizophrenia.
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